XML Financial LLC Sells 6,889 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

XML Financial LLC decreased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 8.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,301 shares of the real estate investment trust’s stock after selling 6,889 shares during the quarter. XML Financial LLC’s holdings in Omega Healthcare Investors were worth $3,146,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in OHI. Versant Capital Management Inc bought a new position in shares of Omega Healthcare Investors during the 2nd quarter worth $26,000. UMB Bank n.a. increased its position in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 516 shares during the period. DiNuzzo Private Wealth Inc. bought a new stake in shares of Omega Healthcare Investors in the 3rd quarter valued at about $33,000. V Square Quantitative Management LLC lifted its position in shares of Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares during the period. Finally, Covestor Ltd boosted its stake in shares of Omega Healthcare Investors by 47.6% during the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after purchasing an additional 431 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently commented on OHI. BMO Capital Markets boosted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a report on Thursday, October 31st. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Six research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $39.70.

Omega Healthcare Investors Stock Performance

Shares of OHI opened at $41.35 on Friday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock has a 50-day moving average of $40.59 and a two-hundred day moving average of $36.32. The stock has a market cap of $11.16 billion, a P/E ratio of 30.40, a P/E/G ratio of 1.27 and a beta of 0.99. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.48%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.